When: Thursday, August 27, 2020, from 1:30 to 3 pm ET
Registration: Register for Medicare Learning Network events.
The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act) outlines national strategies to help address the nation’s opioid crisis. Clinicians and health care systems need information about multimodal pain care options in outpatient and inpatient settings to effectively treat Medicare patients with acute or chronic pain, including complementary care, analgesic medications, and medical devices. The Dr. Todd Graham Pain Management Study will give CMS important information about treatment and outcomes and help us understand the roles of behavioral health, specialty care integration, care planning, health disparities in pain, opioid use, and opioid use disorders treatment.
CMS wants your feedback on:
- What evidence-based treatments, technologies, and models should Medicare cover that it currently does not?
- What barriers impede Medicare clinicians and beneficiaries from utilizing non-opioid treatments and technologies to help treat acute and chronic pain?
- How can Medicare improve care for beneficiaries with pain who have a current or past history of mental or substance use disorder(s) or are at higher risk for these conditions, including people at increased suicide risk?
- How has the COVID-19 public health emergency, including federal waivers and other flexibilities, impacted your ability to treat pain in Medicare beneficiaries and their access to pain treatment?
Target Audience: Clinicians and state and national associations that represent health care providers.